---
title: 'Bayesian meta-analysis for pharmacokinetic parameters'
subtitle: "ACoP11 Conference"
author: "Witold WiÄ™cek"
date: "November 2020"
output: 
  beamer_presentation:
    includes:
      in_header: certarastyle.tex
bibliography: bibliography/zotero_jan2019.bib
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = FALSE, 
                      # fig.retina=4, 
                      comment = "")
library(knitr)
library(dplyr)
library(ggplot2)
library(baggr)
library(broom)
library(scales)
library(broom.mixed)
source("data_preparation_2d6_methods.R")
theme_set(theme_minimal(base_size = 18))


model_inputs_2d6 <- data_2d6 %>% 
  # group_by(domain, parameter, ethnicity) %>%
  mutate(polymorphism = factor(polymorphism, levels = c("PM", "IM", "EM"))) %>% #PM<IM<EM!!!
  rename(ss = sample.size) %>%
  mutate(lgm = log(gm), lv = (log(gsd))^2) %>% 
  # mutate(lgm = ifelse(parameter == "CL", -lgm, lgm)) %>% #CL ---> 1/CL
  select(-gm, -gsd) %>%
  filter(!(polymorphism == "PM" & ethnicity == "A")) %>%
  filter(parameter == "CL") %>%
  # filter(parameter != "Cmax") %>%
  #drop a few smaller drugs
  group_by(drug) %>% mutate(ndrug = n()) %>% ungroup() %>%
  filter(ndrug > 2) %>% 
  filter(!(drug %in% c("r-propafenone", "s-propafenone", "s-metoprolol"))) %>%
  filter(ethnicity == "C") %>%
  # filter(drug %in% data_2d6_fm_gibbs$drug) %>%
  mutate(drug = droplevels(drug)) 
# mutate(parameter = factor(ifelse(parameter == "Cmax", "Cmax", "AUC or 1/CL")))

data_2d6_fm_gibbs_filtered <- filter(data_2d6_fm_gibbs, drug %in% model_inputs_2d6$drug)

stan_input <- with(model_inputs_2d6, 
                   list("ss"=ss, "lgm"=lgm, "lv"=lv, 
                        "drug_eth_par"     = as.numeric(droplevels(interaction(drug, parameter, ethnicity))), 
                        "drug"             = as.numeric(droplevels(drug)), 
                        "polymorphism"     = as.numeric(polymorphism),
                        # "ethnicity"        = as.numeric(ethnicity),
                        "ethnicity"        = rep(1, length(ethnicity)),
                        "parameter"        = as.numeric(droplevels(parameter)),
                        "study"            = as.numeric(droplevels(interaction(study, parameter, ethnicity))),
                        "n"                = nrow(model_inputs_2d6), 
                        "n_train"          = nrow(model_inputs_2d6), 
                        "n_drugs"          = length(unique(drug)),
                        "n_drugs_eth_par"  = length(unique(interaction(drug, parameter, ethnicity))),
                        "n_polymorphisms"  = length(unique(polymorphism)),
                        "n_parameters"     = 1,
                        "n_ethnicities"    = 1,
                        "n_studies"        = length(unique(interaction(study, parameter, ethnicity))),
                        "n_fm_observations"= sum(data_2d6_fm_gibbs$drug %in% drug),
                        "fm_observed"      = data_2d6_fm_gibbs_filtered[, "fm"],
                        "fm_sigma"         = data_2d6_fm_gibbs_filtered[, "sigma_fm"],
                        "fm_observed_drug" = as.numeric(factor(data_2d6_fm_gibbs_filtered$drug, 
                                                               levels = levels(drug)))
                   ))

labels <- with(model_inputs_2d6, 
               list("polymorphism" = levels(droplevels(polymorphism)), 
                    "parameter"    = levels(droplevels(parameter)),
                    "drug"         = levels(droplevels(drug))))

paper_result  <- readRDS("output_2d6_methods/paper_result.rds")

estimated_fm <- data.frame(
  drug = labels$drug,
  tidyMCMC(paper_result, "fm", conf.int = TRUE))
```


# 

Work funded by a grant from European Food Safety Authority and Certara. Special thanks to Dr Jean-Lou Dorne (EFSA), Dr Nadia Quignot (Certara) and Dr Billy Amzal (Certara).



# Introduction

__Objective__: characterise inter-group differences in PK parameters (AUC, clearance, Cmax) using summary-level PK data only from many drugs

__Use case__: deriving uncertainty factors (UFs) for chemical risk assessment

  + Original motivation for UFs: where compound-specific data not available, default values must be used to extrapolate
  + The model applicable in any context where we extrapolate PK across different subgroups
  + Especially useful when comparing more than means only



# Real-world example

UFs for PK parameters due to polymorphic metabolism for CYP2D6 enzyme. 

* Compare poor metabolisers, PM, vs extensive metabolisers, EM.
* Data based on pre-existing literature review. 81 studies of 9 drugs.

Issues:

1. True variances are unknown (small samples)
2. Both means and variances may be impacted 
3. Ratios of PK parameters vary across studies
4. Want to incorporate prior information





# Data: geometric means

Means (logged) for clearance in a subset containing 81 study arms, 9 drugs metabolised by CYP2D6.


```{r, echo = FALSE, height = 4}
model_inputs_2d6 %>% ggplot(aes(y = lgm, x = drug, color = polymorphism)) + geom_jitter(width = .2) + coord_flip() + ylab("mu") + xlab("") + scale_color_manual(values = c("PM" = "red", "EM" = "blue", "IM" = "green"))
```



# Small sample sizes

```{r, warning=FALSE, echo=FALSE}
data_2d6 %>%
  ggplot(aes(sample.size)) + geom_histogram(binwidth = .5, color = "black") + 
  xlim(0, 40) + xlab("Sample size") 
```



# Variable (geometric mean) ratios of EM to PM 


```{r}
filter(data_2d6_ratios, parameter == "CL", 
       ethnicity == "C", !is.na(pm_em), drug %in% labels$drug) %>%
  mutate(em_pm = log(1/pm_em)) %>%
  ggplot(aes(x = drug, y = em_pm)) + 
  geom_point(color = "red", size = 2) +
  coord_flip() +
  labs(y = "log EM/PM ratio of geometric means", x = "")
```



# Variances depend on subgroup

```{r}
model_inputs_2d6 %>% ggplot(aes(x = polymorphism, color = polymorphism, y = lv)) + geom_jitter(size = 3) + ylab("sigma^2") + scale_color_manual(values = c("PM" = "red", "EM" = "blue", "IM" = "green"))
```




# Generic Bayesian model

We model both the true means and true SDs: $\mu_i$'s and $\sigma_i$'s.

For observation $i$ with sample mean and variance (on log scale) $lgm$ and $lv$ and sample size $n$;


$$
\begin{aligned}
lgm_i & \sim \mathcal{N}(\mu_i, \dfrac{\sigma_i}{\sqrt{n_i}}) \\
lv_i  & \sim \Gamma(\frac{n_i-1}{2}, \frac{n_i-1}{2\sigma_i^2})
\end{aligned}
$$

$c(i)$, compound (drug), $s(i)$, study, $g(i)$, group (polymorphism)

$$\begin{aligned}
\mu_i &= \mu^c_{c(i)} + \mu^s_{s(i)} + log(R_i), \\
log(\sigma_i) &= \gamma^c_{c(i)} +\gamma_{g(i)}.
\end{aligned}$$



-----

```{r, echo = FALSE}
include_graphics("model_schematic_both.PNG")
```

For model of polymorphisms we use $R_{i} = EF_{i}\cdot fm_{d(i)}+1-fm_{d(i)}$ with informative priors on fraction metabolised $fm$.




```{r, warning=FALSE, echo=FALSE, cache = TRUE}
#Warning will be due to the geom_density

im_mean <- rstan::extract(paper_result, "mean_ef")[[1]][,1,1,1]
ef_pm <- c(sapply(rstan::extract(paper_result, "sigma_ef")[[1]], function(x) rnorm(100, 0, x)))
ef_em <- c(sapply(rstan::extract(paper_result, "sigma_ef")[[1]], function(x) rnorm(100, 1, x)))
ef_im <- c(apply(cbind(im_mean, rstan::extract(paper_result, "sigma_ef")[[1]]), 1,
               function(x) rnorm(10, x[1], x[2])))
# "theoretical" EFs plot:
fig3a <- rbind(
  data.frame(polymorphism = "PM", ef = ef_pm),
  data.frame(polymorphism = "EM", ef = ef_em),
  data.frame(polymorphism = "IM", ef = ef_im)
  ) %>%
  # filter(ef <= 1, ef >= 0) %>%
  ggplot(aes(ef, group = polymorphism, fill = polymorphism)) + 
  geom_density(alpha = .5) +
  coord_cartesian(x = c(0,1), expand = F) +
  scale_y_continuous(name = NULL, breaks = NULL) +
  scale_x_continuous(name = "enzyme function", breaks = c(0, .5, 1)) +
  scale_fill_discrete(name = "") + 
  theme(plot.margin=unit(c(1,1,1,1),"cm"))

fm <- rstan::extract(paper_result, "fm")[[1]] 
fig3b <- apply((fm * sample(ef_pm[ef_pm > 0], 2000)) + 1 - fm, 2, 
  function(x) c(quantile(x, 0.025), quantile(x, 0.1), mean(x), quantile(x, 0.9), quantile(x, .975))) %>%
  t() %>%
  data.frame() %>%
  setNames(c("lci025", "lci", "ratio", "uci", "uci975")) %>%
  mutate(drug = labels$drug) %>%
  mutate(drug = factor(drug, levels = drug[order(ratio)])) %>%
  ggplot(aes(x = drug, y = ratio)) + 
  geom_point(size = 3) + 
  geom_errorbar(aes(ymin = lci, ymax = uci), lwd = 1.2, width = 0) + 
  geom_errorbar(aes(ymin = lci025, ymax = uci975), width = 0) + 
  geom_jitter(data = filter(data_2d6_ratios, parameter == "CL", 
                           ethnicity == "C", !is.na(pm_em), drug %in% labels$drug), 
             aes(x = drug, y = pm_em), color = "red", size = 2, width = .2) +
  coord_flip() +
  labs(y = "PM/EM ratio in CL", x = "")

m <- rstan::extract(paper_result, "fm")[[1]]
colnames(m) <- labels$drug
estimated_fm <- tidyr::gather(as.data.frame(m), drug, fm) %>%
  mutate(dist = "posterior")
for(i in 1:nrow(data_2d6_fm_gibbs_filtered))
  estimated_fm <- rbind(estimated_fm, data.frame(
  fm = rnorm(10000, data_2d6_fm_gibbs_filtered$fm[i], data_2d6_fm_gibbs_filtered$sigma_fm[i]),
  drug = data_2d6_fm_gibbs_filtered$drug[i],
  dist = "prior"))

fig3c <- estimated_fm %>%
  filter(drug %in% c("metoprolol", "desipramine", "imipramine", "mexiletine", "venlafaxine", "tolterodine")) %>%
  # mutate(drug = paste0(substr(drug, 1, 7), ".")) %>%
  ggplot(aes(fm, group = dist, fill = dist)) + geom_density(alpha=.5) + 
  facet_wrap(~ drug, ncol = 3) + 
  scale_x_continuous(labels = percent, limits = c(0,1)) +
  scale_y_continuous(name = NULL, breaks = NULL) +
  scale_fill_manual(name = "Distribution", values = c("posterior" = "red", "prior" = "skyblue")) +
  theme(legend.position = "bottom")

# gridExtra::grid.arrange(grobs = list(fig3a, fig3c, fig3b), 
#                         layout_matrix = matrix(c(1,2,3,3),2,2), 
#                         widths = c(.5, .5), heights = c(.3, .7))
```



# Comparing prior to posterior: fraction metabolised

```{r, echo=FALSE, warning=FALSE, fig.height=5, fig.width=7}
fig3c
```



# Bayesian posterior: distribution of clearance

```{r}

sigma_drug <- rstan::extract(paper_result, "log_sigma_drug")[[1]]
sigma_poly_em <- rstan::extract(paper_result, "sigma_logeffect_poly")[[1]][,3,1,1]
sigma_pm   <- exp(sigma_drug) #9 columns - 1 per drug
sigma_em   <- exp(sigma_drug + sigma_poly_em) #9 cols

fm <- rstan::extract(paper_result, "fm")[[1]] #9 cols
sigma_ef <- rstan::extract(paper_result, "sigma_ef")[[1]]
ef_pm <- c(sapply(sigma_ef, function(x) abs(rnorm(1, 0, x)))) #draws of EF for PMs
gm_ratio <- fm * ef_pm + 1 - fm

mu_drug <- rstan::extract(paper_result, "mu_drug")[[1]]

# REF vs PM values:
em_min <- pm_min <- em_median <- sigma_em*0
for(i in 1:nrow(sigma_em)) {
  for(j in 1:ncol(sigma_em)) {
    # We use 10 as baseline as it's meaningless in case of log-normals!
    em_median[i,j]  <- qlnorm(.5, mu_drug[i,j], sigma_em[i,j])
    em_min[i,j]  <- qlnorm(.05, mu_drug[i,j], sigma_em[i,j])
    pm_min[i,j]  <- qlnorm(.05, mu_drug[i,j] + log(gm_ratio[i,j]), sigma_pm[i,j])
  }
}

# UF values:
uf <- sigma_em*0
for(i in 1:nrow(sigma_em)) {
  for(j in 1:ncol(sigma_em)) {
    uf[i,j] <- (em_median[i,j])/min((c(em_min[i,j], pm_min[i,j])))
    uf[i,j] <- (em_median[i,j])/pm_min[i,j]
  }
}

# drugs <- c("desipramine",  "fesoterodine", "imipramine",   "metoprolol",   
#            "mexiletine",   "mirtazapine", "propafenone",  "tolterodine",  
#            "venlafaxine")
drugs <- labels$drug
mean_uf <- apply(uf, 2, mean)
lci_uf <- apply(uf, 2, quantile, .1)
uci_uf <- apply(uf, 2, quantile, .9)

mean_uf_df <- data.frame(drugs, mean_uf)
```


```{r distributions of polymorphisms, warning = FALSE,  fig.width = 6, fig.height = 4}
# Compare distributions:
em <- pm <- matrix(0, 20000, 9)
for(i in 1:9){
  em[,i]  <- rlnorm(20000, apply(mu_drug, 2, mean)[i], apply(sigma_em, 2,mean)[i])
  pm[,i]  <- rlnorm(20000, apply(mu_drug, 2, mean)[i] + log(apply(gm_ratio, 2, mean))[i], 
                   apply(sigma_pm, 2, mean)[i])
}

df <- rbind(
  mutate(as.data.frame(log(em)), group="EM"),
  mutate(as.data.frame(log(pm)), group="PM")) %>%
  setNames(c(drugs, "groups"))

tidyr::gather(df, compound, value, -groups) %>%
  filter(compound != "mirtazapine ") %>%
  ggplot(aes(value, group=groups, fill =groups)) + 
  geom_density(alpha = .5) + 
  facet_wrap(compound ~ ., ncol = 4, scales = "free_y") +
  theme_minimal() +
  theme(legend.position = "bottom", axis.text.y = element_blank()) +
  ylab("density") + xlab("clearance (log scale)") +
  scale_fill_viridis_d(name = "Polymorphism")
  # scale_fill_manual(name = "Polymorphism", values = c("PM" = "red", "EM" = "skyblue"))
```




# Ratios: Bayesian posteriors (black) vs data (red) {data-background=#ffffff}

```{r, echo=FALSE, warning=FALSE}
fig3b
```


# Result: UFs depending on both variance and means


```{r, fig.width = 9, fig.height = 6}
par(oma = rep(0,4), mar = rep(1.5,4))
cv <- seq(.05, .95, .1)
sd <- log(cv + 1)
ratios <- seq(1, 10, 1)
uf <- matrix(0, length(sd), length(ratios))
for(i in 1:length(sd))
  for(j in 1:length(ratios))
    uf[i,j] <- exp(qnorm(.95, 0 + log(ratios[j]), sd[i]) - qnorm(.5, 0, sd[i]))
# https://stat.ethz.ch/pipermail/r-help/2004-August/056553.html
pmat <- persp(z = uf, x = cv, y = ratios,
              phi = 15, theta = 35,
              xlab = "CV", ylab = "EM/PM ratio", zlab = "UF 95%", ticktype = "detailed",
              oma = rep(0,4))
trans3d <- function(x,y,z, pmat) {
  tr <- cbind(x,y,z,1) %*% pmat
  list(x = tr[,1]/tr[,4], y= tr[,2]/tr[,4])
}
mean_cv <- exp(apply(sigma_pm, 2, mean)) - 1
mean_cv[6] <- 100 #remove mirtazapine from this plot
points(trans3d(mean_cv,
               1/ apply(gm_ratio, 2, mean),
               mean_uf,
               pmat),
       col = "red",
       cex = 1.2,
       pch = 19)
# text(trans3d((mean_cv + .075),
text(trans3d((mean_cv + .125),
             (1/ apply(gm_ratio, 2, mean) + 1),
             mean_uf,
             pmat),
     toupper(substr(drugs,1,3)),
     # as.character(1:9),
     cex = 1.2,
     pos = c(2, 1, 2, 2, 2, 2, 2, 2, 2, 2),
     col = "red")
```



# Why did we use Bayesian methods?

* Allowed us to use informative priors
    + In our case extra data on fraction metabolised $fm$
* Well-suited to inference on hierarchical models
* We could use it to generalise predictions on different levels
    + e.g. a new population for a known drug, a hypothetical drug
* Easy to implement the model (incl. model for $\sigma$) in MCMC



#

Thank you!

Generic code and more info: `wwiecek.github.io/`, including references to publications

Contact: `witold.wiecek@certara.com`
